6505--Radiopharmaceutical Flucidovine F 18

Closed Pre-Solicitation Posted

Not the latest version. See the latest solicitation from .

Solicitation number
36C26122Q0925
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
North Las Vegas, Nevada 89086, United States

Notice details come from SAM.gov. Updated .

Notice text

Page 2 of 2

PRE-SOLICITATION NOTICE OF INTENT TO SOLE SOURCE

Department of Veterans Affairs (VA) Network Contracting Office (NCO 21) intends to award a sole

source, firm fixed price contract to Trillamed, LLC for 12 doses of F18 Fluciclovine (Axumin).

Fluciclovine, also known as anti-1-amino-3-18F-fluorocyclobutane-1-

carboxylic acid, or as Axumin to be delivered on an as needed basis. The procurement is on behalf of the Department of Veterans Affairs, Veterans Health Administration, Regional Procurement Office West (RPOW), Network Contracting Office (NCO) 21, on behalf of Southern Nevada Healthcare System LAS VEGAS.

The specific items required are as follows:

VA s Gray Market Items terms and conditions apply pursuant to VAAR 852.212-71 Gray Market Items and VAAR 852.212-72 Gray Market and Counterfeit Items. As a result, vendor shall be an OEM, authorized dealer, authorized distributor or authorized reseller for the items identified to be eligible for participation with this acquisition. Vendor must be able to provide the documentation that demonstrates such aforementioned authority.

The solicitation for this action will be posted to beta.sam.gov and all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. After consideration, the Government will determine whether to proceed with the sole source acquisition. Please keep in mind that patient care and choice in the decision is the highest priority to the VA. The solicitation will be posted on or about August 8, 2022.

Please respond to maxwell.derck@va.gov no later than Monday, August 8, 2022 at 16:00 am Pacific time. With your response, please provide evidence showing compliance with the aforementioned Gray Market clauses. Failure to provide the required information may result in a determination that your company is not a viable source.

(End of Notice)

Files

File Type Posted
36C26122Q0925.docx DOCX document

Notice history

Notice Type Posted
6505--Radiopharmaceutical Flucidovine F 18 Latest solicitation Solicitation
This notice Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors